The potential of photodynamic therapy (PDT)—Experimental investigations and clinical use

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 912-929

  Oniszczuk, Anna ^a   Wojtunik Kulesza, Karolina A ^a   Oniszczuk, Tomasz ^b   Kasprzak, Kamila ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Anticancer therapy; Antimicrobial therapy; Free radicals; Photodynamic therapy; Photosensitizers; Psoriasis

Indexed keywords

ANTIBIOTIC AGENT; CURCUMIN; HYPERICIN; MALACHITE GREEN; PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN; XANTHENE DERIVATIVE;

ACNE; ANTIBIOTIC THERAPY; CANCER THERAPY; CHEMOTHERAPY; CLINICAL EFFECTIVENESS; HERPES SIMPLEX; HUMAN; IN VITRO STUDY; OXYGEN CONCENTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSORIASIS; REVIEW; CLINICAL TRIAL (TOPIC); PHOTOCHEMOTHERAPY;

CLINICAL TRIALS AS TOPIC; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84981288121     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.07.058     Document Type: Review

References (166)

1. [1] DePry, J., Brescoll, J., Szczotka-Flynn, L., Rambhatla, P., Lim, H.W., Cooper, K., Phototherapy-related ophthalmologic disorders. Clin. Dermatol. 33 (2015), 247–255.
2. [2] Rkein, A.M., Ozog, D.M., Photodynamic therapy. Dermatol. Clin. 32 (2014), 415–425.
3. [3] Bown, S.G., Photodynamic therapy for photochemists. Philos. Trans. R. Soc. A, 371, 2013, 20120371, 10.1098/rsta.2012.0371.
4. [4] Reddy, S., Kotha, R., Tatapudi, R., Gudapati, S., Madhavai, S., Kiran, S., Photo dynamic therapy in oral diseases. Int. J. Biol. Med. Res. 3 (2012), 1875–1883.
5. [5] Durek, C., Jocham, D., New strategies in photodynamic diagnosis of bladder cancer. Med. Laser Appl. 18 (2003), 41–46.
6. [6] Mitton, D., Ackroyd, R., History of photodynamic therapy in Great Britain. Photodiagn. Photodyn. Ther. 2 (2005), 239–246.
7. [7] Allison, R.R., Downie, G.H., Cuenca, R., Hu, X.H., Childs, C.J., Sibata, C.H., Photosensitizers in clinical PDT. Photodiagn. Photodyn. Ther. 1 (2004), 27–42.
8. [8] Jurczyszyn, K., Ziółkowski, P., Gerber, H., Osiecka, B.J., Potentiality of photodynamic therapy in dentistry—literature review. Dent. Med. Probl. 44 (2007), 255–258.
9. [9] Quirk, B.J., Brandal, G., Donlon, S., Vera, J.C., Mang, T.S., Foy, A.B., Lew, S.M., Girotti, A.W., Jogal, S., LaViolette, P.S., Connelly, J.M., Whelan, H.T., Photodynamic therapy (PDT) for malignant brain tumors—where do we stand?. Photodiagn. Photodyn. Ther. 12 (2015), 530–544.
10. [10] Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell B. 39 (2007), 44–84.
11. [11] Orient, A., Donkó, A., Szabó, A., Leto, T.L., Geiszt, M., Novel sources of reactive oxygen species in the human body. Nephrol. Dial. Transplant. 22 (2007), 1281–1288.
12. [12] Rahman, T., Hosen, I., Islam, M.M., Shekhar, H.U., Oxidative stress and human health. Adv. Biosci. Biotechnol. 3 (2012), 997–1019.
13. [13] Schneider, L.A., Hinrichs, R., Scharffetter-Kochanek, K., Phototherapy and photochemotherapy. Clin. Dermatol. 26 (2008), 464–476.
14. [14] Spring, B.Q., Rizvi, I., Xu, N., Hasan, T., The role of photodynamic therapy in overcoming cancer drug resistance. Photochem. Photobiol. Sci. 14 (2015), 1476–1491.
15. [15] Bacellar, I.O.L., Tsubone, T.M., Pavani, C., Baptista, M.S., Photodynamic efficiency: from molecular photochemistry to cell death. Int. J. Mol. Sci. 16 (2015), 20523–20559.
16. [16] Juzeniene, A., Moan, J., The history of PDT in Norway Part one: identification of basic mechanisms of general PDT. Photodiagn. Photodyn. Ther. 4 (2007), 3–11.
17. [17] Castano, A.P., Demidova, T.N., Hamblin, M.R., Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2 (2005), 1–23.
18. [18] Nowak-Stępniowska, A., Pergoł, P., Padzik-Graczyk, A., Photodynamic therapy for diagnosis and cancer treatment—mechanisms and usage. Post Bioch. 59 (2013), 53–63 (in Polish).
19. [19] Piskorz, J., Nowak, M., Gośliński, T., Therapeutic and diagnostic use of 5- aminolevulinic acid. Terapia i leki 65 (2009), 476–482.
20. [20] Mang, T.S., Lasers and light sources for PDT: past, present and future. Photodiagn. Photodyn. Ther. 1 (2004), 43–48.
21. [21] Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., Hahn, S.M., Hamblin, M.R., Juzeniene, A., Kessel, D., Mladen Korbelik, P., Moan, J., Mroz, P., Nowis, D., Piette, J., Wilson, B.C., Golab, J., Photodynamic therapy of cancer: an update. CA: Cancer J. Clin. 61 (2011), 250–281.
22. [22] Pereira Rosa, L., da Silva, F.C., Antimicrobial photodynamic therapy: a new therapeutic option to combat infections. J. Med. Microb. Diagn. 3 (2014), 1–7.
23. [23] Kim, J., Santos, O.A., Park, J.-H., Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. J. Control. Realase. 191 (2014), 98–104.
24. [24] Gupta, A.K., Ryder, J.E., Photodynamic therapy and topical aminolevulinic acid an overview. Am. J. Clin. Dermatol. 4 (2003), 699–708.
25. [25] Festjens, N., Berghe, T.V., Vandenabeele, P., Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. BBA 1757 (2006), 1371–1387.
26. [26] Liang, L., Bi, W., Tian, Y., Autophagy in photodynamic therapy. Trop. J. Pharm. Res. 15 (2016), 885–889.
27. [27] Glick, D., Barth, S., Macleod, K.F., Autophagy: cellular and molecular mechanisms. J. Pathol. 221 (2010), 3–12.
28. [28] Kessel, D., Oleinick, N.L., Initiation of autophagy by photodynamic therapy. Methods Enzymol. 453 (2009), 1–16.
29. [29] Inguscio, V., Panzarini, E., Dini, L., Autophagy contributes to the death/survival balance in cancer photodynamic therapy. Cells 1 (2012), 464–491.
30. [30] Kubiak, M., Łysenko, L., Gerber, H., Nowak, R., Cell reactions and immune responses to photodynamic therapy in oncology. Postepy Hig. Med. Dosw. 70 (2016), 735–742.
31. [31] Chiaviello, A., Postiglione, I., Palumbo, G., Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview. Cancers 3 (2011), 1014–1041.
32. [32] Wachowska, M., Muchowicz, A., Demkow, U., Immunological aspects of antitumor photodynamic therapy outcome. Cent. Eur. J. Immunol. 40 (2015), 481–485.
33. [33] Chen, B., Pogue, B.W., Luna, J.M., Hardman, R.L., Hoopes, P.J., Hasan, T., Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clin. Cancer Res. 12 (2006), 917–923.
34. [34] Hamblin, M.R., Mróz, P., Advances in Photodynamic Therapy Vascular Targeting in Photodynamic Therapy. 2008, Artech House.
35. [35] Patrice, T., Photodynamic Therapy Mechanisms of Photodynamic Therapy. 2003, European Society for Photobiology.
36. [36] Allison, R.R., Moghissi, K., Photodynamic therapy (PDT): PDT mechanisms. Clin. Endosc. 46 (2013), 24–29.
37. [37] Reginato, E., Wolf, P., Hamblin, M.R., Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J. Immunol. 27 (2014), 1–11.
38. [38] Robertson, C.A., Evans, D.H., Abrahamse, H., Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J. Photochem. Photobiol. B. 96 (2009), 1–8.
39. [39] Kübler, A.C., Photodynamic therapy. Med. Laser Appl. 20 (2005), 37–45.
40. [40] Craig, R.A., McCoy, C.P., Gorman, S.P., Jones, D.S., Photosensitisers—the progression from photodynamic therapy to anti-infective surfaces. Expert Opin. Drug Deliv. 12 (2015), 85–101.
41. [41] Moreira, L.M., Vieira dos Santos, F., Pereira Lyon, J., Maftoum-Costa, M., Pacheco-Soares, C., da Silva, N.S., Photodynamic therapy: porphyrins and phthalocyanines as photosensitizers. Aust. J. Chem. 61 (2008), 741–754.
42. [42] Fioramonti Calixt, G.M., Bernegossi, J., de Freitas, L.M., Fontana, C.R., Chorilli, M., Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review. Molecules 21 (2016), 1–18.
43. [43] De Nunzio, C., Andriole, G.L., Thompson, I.M. Jr., Freedland, S.J., Smoking and prostate cancer: a systematic review. EAU 1 (2015), 28–38.
44. ® sensitizer for photodynamic therapy. J. Photochem. Photobiol. B. 98 (2010), 128–137.
45. [45] Firczuk, M., Winiarska, M., Szokalska, A., Jodlowska1, M., Swiech, M., Bojarczuk, K., Salwa, P., Nowis, D., Approaches to improve photodynamic therapy of cancer. Front. Biosci. 16 (2011), 208–224.
46. [46] Huang, Z., Hsu, Y.-C., Li, L.-B., Wang, L.-W., Song, X.-D., Yow, C.M.N., Lei, X., Musani, A.I., Luo, R.-C., Day, B.J., Photodynamic therapy of cancer—Challenges of multidrug resistance. JIOHS 8 (2015), 1530002–1530015.
47. [47] Laptev, R., Nisnevitch, M., Siboni, G., Malik, Z., Firer, M.A., Intracellular chemiluminescent activation of ligand- photosensitizer conjugate for the targeted destruction of cancer cells. Br. J. Cancer. 95 (2006), 189–196.
48. [48] Bissonnette, R., Tremblay, J.F., Juzenas, P., Boushira, M., Lui, H., Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J. Invest. Dermatol. 119 (2002), 77–83.
49. [49] Carrascosa, J.M., López-Estebaranz, J.L., Carretero, G., Daudén, E., Ferrándiz, C., Vidal, D., Belinchón, I., Sánchez-Regaña, M., Puig, L., Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: a consensus statement of the Spanish Psoriasis Group. Actas Dermosifiliogr. 102 (2011), 175–186.
50. [50] Nobbe, S., Trüeb, R.M., French, L.E., Hofbauer, G.F.L., Herpes simplex virus reactivation as a complication of photodynamic therapy. Photoderm. Photoimmun. Photomed. 27 (2011), 51–52.
51. [51] Borroni, R.G., Barruscotti, S., Carugno, A., Barbaccia, V., Arbustini, E., Brazzelli, V., Usefulness of in vivo photodiagnosis for the identification of tumor margins in recurrent basal cell carcinoma of the face. Photodermatol. Photoimmunol. Photomed. 31 (2015), 195–201.
52. [52] Minamikawa, T., Matsuo, H., Kato, Y., Harada, Y., Otsuji, E., Yanagisawa, A., Tanaka, H., Takamatsu, T., Simplified and optimized multispectral imaging for 5-ALAbased fluorescence diagnosis of malignant lesions. Sci. Rep., 6, 2016, 10.1038/srep25530.
53. [53] Xu, H., Rice, B.W., In-vivo fluorescence imaging with a multivariate curve resolution spectral unmixing technique. J. Biomed. Opt., 14, 2009, 10.1117/1.3258838.
54. [54] Stummer, W., Tonn, J.C., Goetz, C., Ullrich, W., Stepp, H., Bink, A., Pietsch, T., Pichlmeier, U., 5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology andpostoperative imaging. Neurosurgery 74 (2014), 310–319.
55. [55] Yang, Y., Karakhanova, S., Werner, J., Bazhin, A.V., Reactive oxygen species in cancer biology and anticancer therapy. Curr. Med. Chem. 20 (2013), 3677–3692.
56. [56] Liou, G.Y., Storz, P., Reactive oxygen species in cancer. Free Radic. Res. 44 (2010), 479–496.
57. [57] Debele, T.A., Peng, S., Tsai, H.C., Drug carrier for photodynamic cancer therapy. Int. J. Mol. Sci. 16 (2015), 22094–22136.
58. [58] Huang, Z., Hsu, Y.C., Li, L.B., Wang, L.W., Song, X.D., Yow, C.M.N., Lei, X., Musani, A.I., Luo, R.C., Day, B.J., Photodynamic therapy of cancer—Challenges of multidrug resistance. J. Innov. Opt. Health Sci. 8 (2015), 1–13.
59. [59] Capella, M.A., Capella, L.S., A light in muitidrug resistance:photodynamic treatment of multidrug-resistant tumors. J. Biomed. Sci. 10 (2003), 361–366.
60. [60] Bugaj, A.M., Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer—clinician's insight. World J. Methodol. 6 (2016), 65–76.
61. ® Soluble in localized prostate cancer: standardization of the procedure. World J. Urol. 33 (2015), 937–944.
62. [62] Gay, Laura, Baker, Ann-Marie, Graham, Trevor A., F1000 Res. 5 (2016), 1–16.
63. [63] Stanta, G., Jahn, S.W., Bonin, S., Hoefler, G., Tumour heterogeneity: principles and practical consequences. Virchows Arch., 2015, 10.1007/s00428-016-1987-9.
64. [64] Busch, T.M., Xing, X., Yu, G., Yodh, A., Wileyto, E.P., Wang, H.-W., Durduran, T., Zhua, T.C., Wang, K.K.-H., Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy. Photochem. Photobiol. Sci. 8 (2009), 1683–1693.
65. [65] Li, Y.M., Li, L., Yu, C.H., Liu, Y.S., Xu, C.F., A systematic review and meta-analysis of the treatment for Barrett's esophagus. Dig. Dis. Sci. 53 (2008), 2837–2846.
66. [66] Qumseya, B.J., David, W., Wolfsen, H.C., Photodynamic therapy for Barrett's esophagus and esophageal carcinoma. Clin. Endosc. 46 (2013), 30–37.
67. [67] Nava, H.R., Allamaneni, S.S., Dougherty, T.J., Cooper, M.T., Tan, W., Wilding, G., Henderson, B.W., Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus. Laser Surg. Med. 43 (2011), 705–712.
68. [68] Takahira, K., Sano, M., Arai, H., Hanai, H., Apoptosis of gastric cancer cell line MKN45 by photodynamic treatment with Photofrin. Laser Med.Sci. 19 (2004), 89–94.
69. [69] Chen, J.J., Gao, L.J., Liu, T.J., Photodynamic therapy with a novel porphyrin-based photosensitizer against human gastric cancer. Oncol. Lett. 11 (2016), 775–781.
70. [70] Ito, H., Tamura, M., Matsui, H., Majima, H.J., Indo, H.P., Hyodo, I., Reactive oxygen species involved cancer cellular specific 5-aminolevulinic acid uptake in gastric epithelial cells. J. Clin. Biochem. Nutr. 54 (2014), 81–85.
71. [71] Keeley, S.B., Pennathur, A., Gooding, W., Landreneau, R.J., Christie, N.A., Luketich, J., Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann. Surg. Oncol. 14 (2007), 2406–2410.
72. [72] Kimura, M., Miyajima, K., Kojika, M., Kon, T., Kato, H., Photodynamic therapy (PDT) with chemotherapy for advanced lung cancer with airway stenosis. Int. J. Mol. Sci. 16 (2015), 25466–25475.
73. [73] Du, K.L., Mick, R., Busch, T.M., Zhu, T.C., Finlay, J.C., Yu, G., Yodh, A.G., Malkowicz, S.B., Smith, D., Whittington, R., Stripp, D., Hahn, S.M., Preliminary results of interstitial Motexafin Lutetium-Mediated PDT for prostate cancer. Laser. Surg. Med. 38 (2006), 427–434.
74. [74] Marchal, S., Dolivet, G., Lassalle, H.-P., Guillemin, F., Bezdetnaya, L., Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future. Lasers Med. Sci. 30 (2015), 2381–2387.
75. [75] Kästle, M., Grimm, S., Nagel, R., Breusing, N., Grune, T., Combination of PDT and inhibitor treatment affects melanoma cells and spares keratinocytes. Free Radic. Biol.Med. 50 (2011), 305–312.
76. ®: skin cancer PDT phase II clinical trials. Photodiagn. Photodyn. Ther. 7 (2010), 258–267.
77. [77] Biel, M.A., Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem. Photobiol. 83 (2007), 1063–1068.
78. [78] Civantos, F., Photodynamic therapy for head and neck lesions in the subtropics. J. Natl. Compr. Canc. Netw. 10 (2012), 65–68.
79. [79] de Visscher, S.A., Dijkstra, P.U., Tan, I.B., Roodenburg, J.L., Witjes, M.J., mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review. Oral Oncol. 49 (2013), 192–210.
80. [80] Kim, M., Jung, H.Y., Park, H.J., Topical PDT in the treatment of benign skin diseases: principles and new applications. Int. J. Mol. Sci. 16 (2015), 23259–23278.
81. [81] Wan, M.T., Lin, J.Y., Current evidence and applications of photodynamic therapy in dermatology. Clin. Cosmet. Investig. Dermatol. 7 (2014), 145–163.
82. [82] Darlenski, R., Fluhr, J.W., Photodynamic therapy in dermatology: past, present, and future. J. Biomed. Opt, 18, 2013, 10.1117/1.jbo.18.6.061208.
83. [83] Gold, M.H., Efficacy of lasers and PDT for the treatment of acne vulgaris. Skin Ther. Lett. 12 (2008), 1–6.
84. [84] Ding, H.L., Wang, X.L., Wang, H.W., Huang, Z., Successful treatment of refractory facial acne using repeat short-cycle ALA-PDT: Case study. Photodiagn. Photodyn. Ther. 8 (2011), 343–346.
85. [85] Tao, S., Li, F., Cao, L., Xia, R., Fan, H., Fan, Y., Sun, H., Jing, C., Yang, L., Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris. Cell Biochem. Biophys. 73 (2015), 701–706.
86. [86] Mei, X., Shi, W., Piao, Y., Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light in Chinese acne vulgaris patients. Photodermatol. Photoimmunol. Photomed. 29 (2013), 90–96.
87. [87] Hong, S.B., Lee, M.H., Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol. Photoimmunol. Photomed. 21 (2005), 322–325.
88. [88] Huh, S.Y., Na, J.I., Huh, C.H., Park, K.C., The effect of photodynamic therapy using indole-3-acetic acid and green light on acne vulgaris. Ann. Dermatol. 24 (2012), 56–60.
89. [89] Kwon, S.H., Jeong, M.Y., Park, K.C., Youn, S.W., Huh, C.H., Na, J.I., A new therapeutic option for facial seborrhoeic dermatitis: indole-3-acetic acid photodynamic therapy. JEADV 28 (2014), 94–99.
90. [90] Wang, Q., Yuan, D., Liu, W., Chen, J., Lin, X., Cheng, S., Li, F., Duan, X., Use of optical fiber importedi intra-tissue photodynamic therapy for treatment of moderate to severe acne vulgaris. Med. Sci. Monit. 22 (2016), 362–366.
91. [91] Dong, Y., Zgou, G., Chen, J., Shen, Li., Jianxin, Z., Xu, Q., Zhu, Y., A new LED device used for photodynamic therapy in treatment of moderate to severe acne vulgaris. rPhotodiagn. Photodyn. Ther. 13 (2016), 188–195.
92. [92] O'Riordan, K., Akilov, O.E., Hasan, T., The potential for photodynamic therapy in the treatment of localized infections. Photodiagn. Photodyn. Ther. 2 (2005), 247–262.
93. [93] Rosa, L.P., da Silva, F.C., Antimicrobial photodynamic therapy: a new therapeutic option to combat infections. J. Med. Microb. Diagn., 3, 2014, 158, 10.4172/2161-0703.1000158.
94. [94] Yildirim, C., Karaarslan, E.S., Ozsevik, S., Zer, Y., Sari, T., Usumez, A., Antimicrobial efficiency of photodynamic therapy with different irradiation durations. Eur. J. Dent. 7 (2013), 469–473.
95. [95] Javed, F., Samaranayake, L.P., Romanos, G.E., Treatment of oral fungal infections using antimicrobial photodynamic therapy: a systematic review of currently available evidence. Photochem. Photobiol. Sci. 13 (2014), 726–734.
96. [96] Castano, A.P., Demidova, T.N., Hamblin, M.R., Mechanisms in photodynamic therapy. Part one. Photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 1 (2004), 279–293.
97. [97] Nitzan, Y., Dror, R., Ladan, H., Malik, Z., Kimel, S., Gottfried, V., Structure—activity relationship of porphines for photoinactivation of bacteria. Photochem. Photobiol. 62 (1995), 342–347.
98. [98] Nakonechny, F., Nisnevitch, M., Nitzan, Y., Firer, M.A., New Techniques in Antimicrobial Photodynamic Therapy: Scope of Application and Overcoming Drug Resistance in Nosocomial Infections. Science Against Microbial Pathogens: Communicating Current Research and Technological Advances. Méndez-Vilas, A., (eds.), 2011, Formatex Research Center, 684–691.
99. [99] Beaulac, C., Clément, S., Hawari, J., Lagacé, J., Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection. Antimicrob. Agents Chem. 40 (1996), 665–669.
100. [100] Robertson, C.A., Evans, D.H., Abrahamse, H., Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J. Photochem. Photobiol. B 96 (2009), 1–8.
101. [101] Carpenter, S., Fehr, M.J., Kraus, G.A., Petrich, J.W., Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 12273–12277.
102. [102] Haag, P.A., Steiger-Ronay, V., Schmidlin, P.R., The in vitro antimicrobial efficacy of PDT against periodontopathogenic bacteria. Int. J. Mol. Sci. 16 (2015), 27327–27338.
103. [103] Usacheva, M.N., Teichert, M.C., Biel, M.A., The role of the methylene blue and toluidine blue monomers and dimers in the photoinactivation of bacteria. J. Photochem. Photobiol. B 71 (2003), 87–98.
104. [104] Wainwright, M., Phoenix, D.A., Laycock, S.L., Wareing, D.R.A., Wright, P.A., Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett. 160 (1998), 177–181.
105. [105] OO'Neill, J., Wilson, M., Wainwright, M., Comparative antistreptococcal activity of photobactericidal agents. J. Chemother. 15 (2003), 329–334.
106. [106] Topaloglu, N., Gulsoy, M., Yuksel, S., Antimicrobial photodynamic therapy of resistant bacterial strains by indocyanine green and 809-nm diode laser. Photomed. Laser Surg. 31 (2013), 155–162.
107. [107] Kubin, A., Wierrani, F., Jindra, R.H., Loew, H.G., Grünberger, W., Ebermann, R., Alth, G., Antagonistic effects of combination photosensitization by hypericin, meso-tetrahydroxyphenylchlorin (mTHPC) and photofrin II on Staphylococcus aureus. Drugs Exp. Clin. Res. 25 (1999), 13–21.
108. [108] Wierrani, F., Experimental investigations and clinical use of photodynamic therapy (PDT) in the Rudolf Foundation Hospital. Gynakol Geburtshilfliche Rundsch. 39 (1999), 217–225.
109. [109] Griffiths, M.A., Wren, B.W., Wilson, M., Killing of methicillinresistant Staphylococcus aureus in vitro using aluminium disulphonated phthalocyanine, a light-activated antimicrobial agent. J. Antimicrob. Chemother. 40 (1997), 873–876.
110. [110] Lasocki, K., Szpakowska, M., Grzybowski, J., Graczyk, A., Examination of antibacterial activity of the photoactivated arginine haematoporphyrin derivative. Pharmacol. Res. 39 (1999), 181–184.
111. [111] Szpakowska, M., Lasocki, K., Grzybowski, J., Graczyk, A., Photodynamic activity of the haematoporphyrin derivative with rutin and arginine substituents (HpD-rut(2)-arg(2)) against Staphylococcus aureus and Pseudomonas aeruginosa. Pharmacol. Res. 44 (2001), 243–246.
112. [112] Embleton, M.L., Nair, S.P., Cookson, B.D., Wilson, M., Selective lethal photosensitization of methicillin-resistant Staphy lococcus aureus using an IgG-Tin(IV) chlorin e6 conjugate. J. Antimicrob. Chemother. 50 (2002), 857–864.
113. [113] Embleton, M.L., Nair, S.P., Cookson, B.D., Wilson, M., Antibody directed photodynamic therapy of methicillin resistant Staphylococcus aureus. Microb. Drug. Resist. 10 (2004), 92–97.
114. [114] Gad, F., Zahra, T., Hasan, T., Hamblin, M.R., Effects of growth phase and extracellular slime on photodynamic inactivation of Gram-positive pathogenic bacteria. Antimicrob. Agents Chemother. 48 (2004), 2173–2178.
115. [115] Rolim, J.P.M.L., de-Melo, M.A.S., Guedes, S.F., Albuquerque-Filho, F.B., de Souza, J.R., Nogueira, N.A.P., Zanin, I.C.J., Rodrigues, L.K.A., The antimicrobial activity of photodynamic therapy against Streptococcus mutans using different photosensitizers. J. Photochem. Photobiol. B 106 (2012), 40–46.
116. [116] Hakimiha, N., Khoei, F., Bahador, A., Fekrazad, R., The susceptibility of Streptococcus mutans to antibacterial photodynamic therapy: a comparison of two different photosensitizers and light sources. J. Appl. Oral Sci. 22 (2014), 80–84.
117. [117] De Sordi, L., Butt, M.A., Pye, H., Kohoutova, D., Mosse, C.A., Yahioglu, G., Stamati, I., Deonarain, M., Battah, S., Ready, D., Allan, E., Mullany, P., Lovat, L.B., Development of photodynamic antimicrobial chemotherapy (PACT) for clostridium difficile. PLoS One, 10, 2015, 10.1371/journal.pone.0135039.
118. [118] Bhatti, M., MacRobert, A., Henderson, B., Wilson, M., Exposure of porphyromonas gingivalis to red light in the presence of the light-activated antimicrobial agent toluidine blue decreases membrane fluidity. Curr. Microbiol. 45 (2002), 118–122.
119. [119] Bhatti, M., MacRobert, A., Meghji, S., Henderson, B., Wilson, M., Effect of dosimetric and physiological factors on the lethal photosensitization of Porphyromonas gingivalis in vitro. Photochem. Photobiol. 65 (1997), 1026–1031.
120. [120] Matevski, D., Weersink, R., Tenenbaum, H.C., Wilson, B., Ellen, R.P., Lépine, G., Lethal photosensitization of periodontal pathogens by a red-filtered Xenon lamp in vitro. J. Periodontal Res. 38 (2003), 428–435.
121. [121] Soukos, N.S., Ximenez-Fyvie, L.A., Hamblin, M.R., Socransky, S.S., Hasan, T., Targeted antimicrobial photochemotherapy. Antimicrob. Agents Chemother. 42 (1998), 2595–2601.
122. [122] Wilson, M., Dobson, J., Sarkar, S., Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol. Immunol. 8 (1993), 182–187.
123. [123] Voos, A.C., Kranz, S., Tonndorf-Martini, S., Voelpel, A., Sigusch, H., Staudte, H., Albrecht, V., Sigusch, B.W., Photodynamic antimicrobial effect of safranine O on an ex vivo periodontal biofilm. Laser. Surg. Med. 46 (2014), 235–243.
124. [124] Dobson, J., Wilson, M., Sensitization of oral bacteria in biofilms to killing by light from a low-power laser. Arch. Oral Biol. 37 (1992), 883–887.
125. [125] Jeon, Y.M., Lee, H.S., Jeong, D., Oh, H.K., Ra, K.H., Lee, M.Y., Antimicrobial photodynamic therapy using chlorin e6 with halogen light for acne bacteria-induced inflammation. Life Sci. 124 (2015), 56–63.
126. [126] Chui, C., Aoki, A., Takeuchi, Y., Sasaki, Y., Hiratsuka, K., Abiko, Y., Izumi, Y., Antimicrobial effect of photodynamic therapy using high-power blue light-emitting diode and red-dye agent on Porphyromonas gingivalis. J. Periodont. Res. 48 (2013), 696–705.
127. [127] Chan, Y., Lai, C.H., Bactericidal effects of different laser wavelengths on periodontopathic germs in photodynamic therapy. Laser. Med. Sci. 18 (2003), 51–55.
128. [128] Ragàs, X., Agut, M., Nonell, S., Singlet oxygen in Escherichia coli: New insights for antimicrobial photodynamic therapy. Free Radic. Biol. Med. 49 (2010), 770–776.
129. [129] Tavares, A., Carvalho, C.M.B., Faustino, M.A., Neves, M.G.P.M.S., Tomé, J.P.C., Tomé, A.C., Cavaleiro, J.A.S., Cunha, Â., Gomes, N.C.M., Alves, E., Almeida, A., Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar. Drugs 8 (2010), 91–105.
130. [130] Monzavi, A., Chinipardaz, Z., Mousavi, M., Fekrazad, R., Moslemi, N., Azaripour, A., Bagherpasand, O., Chiniforush, N., Antimicrobial photodynamic therapy using diode laser activated indocyanine green as an adjunct in the treatment of chronic periodontitis: a randomized clinical trial. Photodiagn. Photodyn. Ther. 14 (2016), 93–97.
131. [131] Melo, M.A.S., Rolim, J.P.M.L., Passos, V.F., Lima, R.A., Zanin, I.C.J., Codes, B.M., Rocha, S.S., Rodrigues, L.K.A., Photodynamic antimicrobial chemotherapy and ultraconservativecaries removal linked for management of deep caries lesions. Photodiagn. Photodyn. Ther. 12 (2015), 581–586.
132. [132] Jurič, I.B., Plečko, V., Pandurić, D.G., Anić, I., The antimicrobial effectiveness ofphotodynamic therapy used as an additionto the conventional endodonticre-treatment: a clinical study. Photodiagn. Photodyn. Ther. 11 (2014), 549–555.
133. [133] Araújo, P.V., Correia-Silva, J.F., Gomez, R.S., Massara, M.L., Cortes, M.E., Poletto, L.T., Antimicrobial effect of photodynamic therapy in carious lesions in vivo using culture and real-time PCR methods. Photodiagn. Photodyn Ther. 12 (2015), 401–407.
134. [134] Muhammad, O.H., Chevalier, M., Rocca, J.P., Brulat-Bouchard, N., Medioni, E., Photodynamic therapy versus ultrasonicirrigation: interaction with endodonticmicrobial biofilm an ex vivo study. Photodiagn. Photodyn. Ther. 11 (2014), 171–181.
135. ® system plus photodynamic therapy associated with calcium hydroxide against intracanal Enterococcus faecalis. Int. Endod. J. 46 (2013), 499–505.
136. [136] Berneburg, M., Herzinger, T., Rampf, J., Hoetzenecker, W., Guenova, E., Meisner, C., Maetzke, J., Schaefer, T., Eberlein, B., Scharffetter-Kochanek, K., Rocken, M., Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective open, randomized, multicentre study. Br. J. Dermatol. 169 (2013), 704–708.
137. [137] Gu, X., Nylander, E., Coates, P.J., Nylander, K., Oxidation reduction is a key process for successful treatment of psoriasis by narrow-band UVB phototherapy. Acta Derm. Venereol. 95 (2015), 140–146.
138. [138] Choi, Y.M., Adelzadeh, L., Wu, J.J., Photodynamic therapy for psoriasis. J. Dermatol. Treat. 26 (2015), 202–207.
139. [139] Pardasani, A.G., Feldman, S.R., Clark, A.R., Treatment of psoriasis: an algorithm-based approach for primary care physicians. Am. Fam. Phys. 61 (2000), 725–733.
140. [140] Oniszczuk, Waksmundzka-Hajnos, K., Głowniak, K., Comparison of matrix-solid phase dispersion and liquid?solid extraction connected with solid-phase extraction in the quantification of selected furanocoumarins from fruits of Heracleum leskowii by high performance liquid chromatography. Ind. Crops Prod. 50 (2013), 131–136.
141. [141] Jain, V.K., Aggarwal, K., Jain, K., Bansal, A., Narrow-band UV-B phototherapy in childhood psoriasis. Int. J. Dermatol. 46 (2007), 320–322.
142. [142] Soliman, A., Nofal, E., Nofal, A., El Desouky, F., Asal, M., Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis. J. Dermatol. Treat. 26 (2015), 528–534.
143. [143] Almuslet, N.A., Osman, A.E., Investigation of the effect of low power laser used in photodynamic therapy for treatment of psoriasis. Photon Lasers Med. 1 (2012), 309–317.
144. [144] Calzavara-Pinton, P.G., Venturini, M., Sala, R., Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J. Eur. Acad. Dermatol. Venereol. 21 (2007), 293–302.
145. [145] Lee, Y., Baron, E.D., Photodynamic therapy: current evidence and applications in dermatology. Semin. Cutan. Med. Surg. 30 (2011), 199–209.
146. [146] Smits, T., Kleinpenning, M.M., van Erp, P.E., van de Kerkhof, P.C., Gerritsen, M.J., A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Br. J. Dermatol. 155 (2006), 429–436.
147. [147] Robinson, D.J., Collins, P., Stringer, M.R., Vernon, D.I., Stables, G.I., Brown, S.B., Sheehan-Dare, R.A., Improved response of plaque psoriasis after multiple treatments with topical 5- aminolaevulinic acid photodynamic therapy. Acta Derm. Venereol. 79 (1999), 451–455.
148. [148] Redbord, K.P., Hanke, C.W., Topical photodynamic therapy for dermatologic disorders: results and complications. J. Drugs Dermatol. 6 (2007), 1197–1202.
149. [149] Ilknur, T., Akarsu, S., Aktan, S., Ozkan, S., Comparison of the effects of pulsed dye laser pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques. Dermatol. Surg. 32 (2006), 49–55.
150. [150] Radakovic-Fijan, S., Blecha-Thalhammer, U., Schleyer, V., Szeimies, R.M., Zwingers, T., Hönigsmann, H., Tanew, A., Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br. J. Dermatol. 152 (2005), 279–283.
151. [151] Miller, J.D., Baron, E.D., Scull, H., Hsia, A., Berlin, J.C., McCormick, T., Colussi, V., Kenney, M.E., Cooper, K.D., Oleinick, N.L., Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol. Appl. Pharmacol. 224 (2007), 290–299.
152. [152] Salah, M., Samy, N., Fadel, M., Methylene blue mediated photodynamic therapy for resistant plaque psoriasis. J. Drugs Dermatol. 8 (2009), 42–49.
153. [153] Rook, A.H., Wood, G.S., Duvic, M., Vonderheid, E.C., Tobia, A., Cabana, B., A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. J. Am. Acad. Dermatol. 63 (2010), 984–990.
154. [154] Arduino, P.G., Porter, S.R., Herpes Simplex Virus Type I infection: overviev on relevant clinic- pathological features. J. Oral. Pathol. Med. 37 (2008), 107–121.
155. [155] Corey, L., Synergistic copathogens- HIV-1 and HSV-2. N. Engl. J. Med. 356 (2007), 854–856.
156. [156] Arduino, P.G., Porter, S.R., Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 12 (2006), 254–270.
157. [157] Fatahzadeh, M., Schwartz, R.A., Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J. Am. Acad. Dermatol. 57 (2007), 737–763.
158. [158] Raborn, G.W., Grace, M.G., Recurrent herpes simplex labialis: selected therapeutic options. J. Can. Dent. Assoc. 69 (2003), 498–503.
159. [159] Spruance, S.L., Kriesel, J.D., Treatment of herpex simplex labialis. Herpes 9 (2002), 64–69.
160. [160] Marotti, J., Aranha, A.C., Eduardo, C., Ribeiro, M.S., Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed. Laser Surg. 27 (2009), 357–363.
161. [161] Karu, T.I., Molecular mechanism of the therapeutic effect of low- intensity laser irradiation. Laser Life Sci. 2 (1988), 53–74.
162. [162] Tunér, J., Laser phototherapy (LPT) in dentistry. Int. CE Mag. Laser Dent. 1 (2011), 8–17.
163. [163] Kudo, H.C., Inomata, K., Okajima, K., Moteji, M., Oshiro, T., Low- level laser therapy: pain attenuation mechanisms. Laser Ther. 2 (1998), 3–6.
164. [164] Hagiwara, S., Iwasaka, H., Okuda, K., Noguchi, T., GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Laser. Surg. Med. 39 (2007), 797–802.
165. [165] Ramalho, K.M., Rocha, R.G., Correa-Aranha, A.C., Cunha, S.R., Simões, A., Campos, L., Eduardo, C., Treatment of herpes simplex labialis in macule and vesicle phases with photodynamic therapy. Report of two cases. Photodiagn. Photodyn. Ther. 12 (2015), 321–323.
166. [166] Bello-Silva, M.S., de Freitas, P.M., Aranha, A.C., Lage-Marques, J.L., Simões, A., de Paula, E.C., Low- and high intensity lasers in the treatment of herpes simplex virus 1 infection. Photomed. Laser Surg. 28 (2010), 135–139.